IP Library Granted Patent US 10,213,391
Granted Patent B2
US 10,213,391 · App. 15/307,124 · Granted Feb 26, 2019

Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation

Inventor: Mewa Singh (Zachary, LA)
A61K31/12A61K9/0095A61K9/2009A61K9/2013A61K9/2027A61K9/2036A61K9/2054A61K9/2059A61K9/2846A61K9/485A61K9/4866A61K31/047A61K31/121A61K31/352A61K33/06A61K36/185A61K36/9066A61K36/9068
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,213,391
App. No.
15/307,124
Granted
Feb 26, 2019
Kind
B2
Abstract

The present invention comprises compositions comprising therapeutically effective amounts of CBD and curcumin in various combinations to treat pain. CBD and curcumin are preferably from natural sources. A method of using the combination of CBD and curcumin compositions to treat pain is also described.

Claims (20)

1. A tablet or capsule consisting essentially of curcumin, cannabidiol, talc, methacrylic acid-ethyl acrylate copolymer, triethyl citrate, and a simethicone emulsion.

2. The composition of claim 1 , further consisting essentially of a component selected from the group consisting of magnesium and ginger.

3. The composition of claim 1 , wherein the cannabidiol and curcumin are from natural sources.

4. The composition of claim 1 , wherein the natural source of cannabidiol is hemp and the natural source of curcumin is turmeric.

5. The composition of claim 4 , wherein the cannabidiol is a liquid or a powder extract of cannabis and the curcumin is a liquid or a powder extract from a turmeric root.

6. The composition of claim 5 , wherein the cannabidiol extract is at least 80% (w/w) cannabidiol to the total cannabinoid content in the composition.

7. The composition of claim 5 , wherein the curcumin extract is at least 2% by weight curcuminoid.

8. The composition of claim 5 , wherein the weight ratio of cannabidiol extract to curcumin extract is about 1:1 to about 1:5.

9. The composition of claim 5 , wherein the weight ratio of cannabidiol in the cannabidiol extract and curcuminoid in the curcumin extract is about 1:1 to about 1:10.

10. The composition of claim 5 , wherein the composition is a water soluble dosage form.

11. The dosage form of claim 10 , wherein the dosage form is a capsule, tablet or liquid.

12. The dosage form of claim 11 , wherein the dosage form is a capsule.

13. A method of treating pain in a human consisting essentially of:

a) selecting a human in need of treatment for pain;

b) administering to the patient in need of treatment for pain a therapeutically effective amount of tablet or capsule consisting essentially of curcumin, cannabidiol, talc, methacrylic acid-ethyl acrylate copolymer, triethyl citrate, and a simethicone emulsion, wherein the patient in need of treatment for pain is effectively treated.

14. The method as claimed in claim 13 , wherein the pain is selected from the group consisting of acute pain and chronic pain.

15. A method of treating pain consisting essentially of administering to a patient in need of treatment for pain the composition of claim 2 .

16. A method of treating pain consisting essentially of administering to a patient in need of treatment for pain the composition of claim 4 .

17. A method of treating pain consisting essentially of administering to a patient in need of treatment for pain the composition of claim 5 .

18. A method of treating pain consisting essentially of administering to a patient in need of treatment for pain the capsule of claim 12 .

Continuity (2)
Provisional Application 61989158 · May 6, 2014
Related Publication 20170042835A1 · Feb 16, 2017
Cited By (3)
US 12,458,620 US 12,465,589 US 12,708,633